Skip to main content
. Author manuscript; available in PMC: 2007 Mar 7.
Published in final edited form as: Cancer. 2005 Dec 15;104(12 Suppl):2999–3005. doi: 10.1002/cncr.21524

TABLE 3.

Barriers and Facilitators to Clinical Trial Participation

Variable No. of responses (%)
Barriers to clinical trials participation (n = 20 respondents)
 Uncertainties of clinical trials (risks, effectiveness, side effects) 11 (55)
 Language barrier 3 (15)
 Insufficient information 3 (15)
 Lack of financial and other support 2 (10)
Facilitators for clinical trials participation (n = 25 respondents)
 No other effective treatments 10 (40)
 Recommended by trusted individual (including oncologist) 9 (36)
 Altruism 8 (32)
 More information 6 (24)
 Good treatment effectiveness 3 (12)
 Not harmful to the body 3 (12)
HHS Vulnerability Disclosure